Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 252

1.

To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Ann Surg. 2017 May 4. doi: 10.1097/SLA.0000000000002285. [Epub ahead of print]

PMID:
28475558
2.

Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Surg Obes Relat Dis. 2016 Dec 23. pii: S1550-7289(16)30877-2. doi: 10.1016/j.soard.2016.12.013. [Epub ahead of print]

PMID:
28223087
3.

Current challenges in providing bariatric surgery in France: A nationwide study.

Czernichow S, Paita M, Nocca D, Msika S, Basdevant A, Millat B, Fagot-Campagna A.

Medicine (Baltimore). 2016 Dec;95(49):e5314.

4.

Obesity Management in Europe: Current Status and Objectives for the Future.

Uerlich MF, Yumuk V, Finer N, Basdevant A, Visscher TL.

Obes Facts. 2016;9(4):273-83. doi: 10.1159/000445192. Epub 2016 Aug 20.

5.

[Bariatric surgery in teenagers].

Basdevant A.

Rev Prat. 2015 Jun;65(6):760-2. French.

PMID:
26298894
6.

[Pregnancy and bariatric surgery: Critical points].

Ciangura C, Nizard J, Poitou-Bernert C, Dommergues M, Oppert JM, Basdevant A.

J Gynecol Obstet Biol Reprod (Paris). 2015 Jun;44(6):496-502. doi: 10.1016/j.jgyn.2015.01.010. Epub 2015 Feb 25. Review. French.

7.

Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.

Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA.

Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 2014 Dec 24.

PMID:
25544682
8.

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.

Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V; LIDO Study Group.

Aliment Pharmacol Ther. 2014 Nov;40(10):1209-22. doi: 10.1111/apt.12963. Epub 2014 Sep 29.

9.

Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases.

Nascimbeni F, Lebray P, Fedchuk L, Oliveira CP, Alvares-da-Silva MR, Varault A, Ingiliz P, Ngo Y, de Torres M, Munteanu M, Poynard T, Ratziu V; LIDO Study Group.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):763-71.e1-6. doi: 10.1016/j.cgh.2014.07.037. Epub 2014 Jul 30.

PMID:
25086193
10.

[What about a new job in the health system: The coordinator of care].

Meininger V, Fontaine B, Grabli D, Basdevant A, Clement K, Vignot M, Cordesse V.

Presse Med. 2014 Oct;43(10 Pt 1):1031-3. doi: 10.1016/j.lpm.2014.06.006. Epub 2014 Jul 26. French. No abstract available.

PMID:
25073809
11.

Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.

Gesquiere I, Aron-Wisnewsky J, Foulon V, Haggege S, Van der Schueren B, Augustijns P, Bouillot JL, Clement K, Basdevant A, Oppert JM, Buyse M.

Obes Surg. 2014 Nov;24(11):1896-903. doi: 10.1007/s11695-014-1325-8.

PMID:
24947346
12.

ZHENG May Contribute to Obesity Phenotypes Based on Body Composition: A Pilot Study on the Traditional Chinese Medicine Approach.

Tao F, Lu H, Oppert JM, Basdevant A.

Evid Based Complement Alternat Med. 2014;2014:580803. doi: 10.1155/2014/580803. Epub 2014 Mar 10.

13.

Dietary intervention impact on gut microbial gene richness.

Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, Gougis S, Rizkalla S, Batto JM, Renault P; ANR MicroObes consortium, Doré J, Zucker JD, Clément K, Ehrlich SD.

Nature. 2013 Aug 29;500(7464):585-8. doi: 10.1038/nature12480. Erratum in: Nature. 2013 Oct 24;502(7472)580.

PMID:
23985875
14.

Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes.

Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, Zucker JD, Doré J, Clément K.

Am J Clin Nutr. 2013 Jul;98(1):16-24. doi: 10.3945/ajcn.113.058743. Epub 2013 May 29.

15.

Pharmacokinetics of immunomodulator treatments after roux-en-y bypass in obese patient.

Aron-Wisnewsky J, Lemaitre F, Clément K, Bouillot JL, Fernandez C, Basdevant A, Oppert JM, Buyse M.

J Clin Pharmacol. 2013 Jul;53(7):779-84. doi: 10.1002/jcph.99. Epub 2013 May 14. No abstract available.

PMID:
23670812
16.

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.

Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, Ratziu V; LIDO Study Group.

J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.

PMID:
23665288
17.

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.

Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, Clément K, Poitou C.

Int J Obes (Lond). 2013 Sep;37(9):1198-203. doi: 10.1038/ijo.2012.228. Epub 2013 Jan 15.

PMID:
23318724
18.

Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities.

Julia C, Ciangura C, Capuron L, Bouillot JL, Basdevant A, Poitou C, Oppert JM.

Diabetes Metab. 2013 Apr;39(2):148-54. doi: 10.1016/j.diabet.2012.10.008. Epub 2013 Jan 10.

PMID:
23313223
19.

Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

Coupaye M, Lorenzini F, Lloret-Linares C, Molinas C, Pinto G, Diene G, Mimoun E, Demeer G, Labrousse F, Jauregi J, Laurier V, Basdevant A, Polak M, Thuilleaux D, Tauber M, Poitou C.

J Clin Endocrinol Metab. 2013 Feb;98(2):E328-35. doi: 10.1210/jc.2012-2881. Epub 2013 Jan 2.

PMID:
23284006
20.

Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery.

Le Beyec J, Cugnet-Anceau C, Pépin D, Alili R, Cotillard A, Lacorte JM, Basdevant A, Laville M, Clément K.

J Clin Endocrinol Metab. 2013 Feb;98(2):E397-402. doi: 10.1210/jc.2012-2779. Epub 2012 Dec 28.

PMID:
23275530

Supplemental Content

Loading ...
Support Center